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Gastroesophageal reflux disease is common. Fundoplication is very effective
for those patients who fail medical therapy, particularly those with an incompe-
tent lower esophageal sphincter. Open surgery is reported to achieve cure rates
in excess of90 percent. Laparoscopic fundoplication has been performed since
1991. The early experience with this procedure is reviewed. Results: 1992 cases
were reported in the literature. The mortality rate was 0.1 percent. Operative
complications occurred as follows: 0.9 percent esophagogastric perforation rate;
0.6 percent bleeding rate (requiring transfusion); and 0.6 percent pneumothorax
rate. No splenectomies were reported. 4.8 percent of patients required conver-
sion to the open procedure. As experience with theprocedure is gained this con-
version rate decreases. Recurrent reflux postoperatively is 3.4 percent, but fol-
low-up is short (range: 0 to 36 months; mean: two years). Dysphagia requiring
dilatation occurs in 3.5 percent of patients. Gas bloat occurs in 0 to 24 percent
ofpatients. These results compare favorably with the published results of med-
ical therapy and the open fundoplication.
Conclusions: The early experience with laparoscopic fundoplication appears
promising and provides an attractive alternative to long-term medical therapy
and to open surgery in appropriate patients. Long-term follow-up is awaited.
INTRODUCTION
The lower esophageal barrier against reflux of gastric acid into the esophagus relies
on several factors. The most important is the maintenance ofa continuous resting pressure
at the lower esophageal sphincter area. This pressure is produced by a complex interplay
of lower esophageal smooth muscle tone, the effect of the diaphragmatic crura, intra-
abdominal pressure and the anatomic configuration ofthe esophagogastric angle. Almost
all patients with severe gastroesophageal reflux disease who fail medical therapy are
found to have a subnormal lower esophageal sphincter pressure [1]. Medical therapy is
aimed at the suppression ofgastric acid secretion since there are no drugs that effectively
increase loweresophageal sphincter tone orsignificantly speed gastric emptying sufficient
to keep the gastric reservoir empty ofacid for reflux. The healing rate ofreflux esophagi-
tis is poor with H2 blockers and somewhat better with omeprazole (Table 1) [2, 3].
However, even on continuous omeprazole therapy at a dose of 20 to 40 mg per day, the
relapse rate ofesophagitis is extremely high, with 50 percent ofpatients relapsing during
the first 200 days oftherapy [4]. The cost ofmedical therapy is high, with estimates in the
range of$2000 per year for severe reflux disease [5]. With the high relapse rate on med-
ical therapy combined with the cost, inconvenience and need for continuous treatment, it
is not surprising that patients are willing to seek the surgical alternative.
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Table 1. Healing rate ofH2 blocker therapy on esophagitis.
6 weeks 12 weeks
Mild esophagitis 65-70% 80-90%
Moderate esophagitis 40-45% 60-65%
Severe esophagitis 20-30% 30-50%
Surgery for gastroesophageal reflux disease began in the 1940s with the realization
that the presence of a hiatal hernia was associated with reflux of acid into the esophagus
and resultant mucosal damage. Early surgical procedures concentrated on reducing the
herniated stomach and tightening the crura. This was met with varied success. As knowl-
edge of the anatomic and physiologic mechanisms of reflux developed, it became clear
thatit was possible to surgically reconstruct the loweresophageal sphincter barrieragainst
reflux. Several operations have been developed including the Nissen 3600 fundoplication,
the Hill gastropexy, the Belsey transthoracic "inkwell" procedure and the Toupet posteri-
or partial fundoplication. Thoracic surgeons have proposed an esophageal lengthening
operation for the rare condition ofesophageal shortening due to reflux damage. The most
popular operation has been the Nissen fundoplication. The reasons why this procedure is
such an effective antireflux procedure are shown in Table 2. Until 1991, all ofthese pro-
cedures required either a laparotomy or thoracotQmy, with their attendant morbidity and
mortality. Largely due to poor selection of surgical cases and surgeon inexperience, the
results of surgery were not uniformly successful. However, excellent results with 90 per-
cent success at 10 years were reported by surgeons with extensive experience with these
procedures [6].
Following on the success of minimally invasive surgery for the operation of chole-
cystectomy, surgeons in early 1991 began exploring the possibility ofcarrying out laparo-
scopically directed fundoplications [7]. Early success with this operation has led to a
reawakening of interest in the surgical therapy of gastroesophageal reflux disease.
Between 1991 and 1995, almost 2000 cases have been reported in the literature with some
series containing several hundred cases [8-25]. Both patients and referring physicians
have been pleased with the minimal morbidity, short hospital stay and rapid return to nor-
mal activities offered by the laparoscopic technique. The results after four years are at
least as good as those seen after the open operation. In this article, the results ofthis early
experience with laparoscopic fundoplication will be presented.
METHODS
The worldwide published literature was reviewed. Between 1991 and 1995, reports
on laparoscopic Nissen fundoplication included 1992 patients. Preliminary data from a
French multicenter trial were only available for analysis of mortality, overall morbidity,
Table 2. Reasons why Nissen fundoplication prevents reflux.
* Increased length ofintra-abdominal esophagus
* Rise in resting lower esophageal sphincter pressure
* Accentuation ofangle of His
* Accentuation ofmucosal flap valve at esophagogastric junction
* Angulation oflower esophagus over the funoplication
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conversion rate and incidence of splenectomy. Other analyses use 1451 patients as the
denominator (which excludes the patients in the French multicenter trial). Occasionally
the denominator changes ifthe relevant data were not available in some ofthe reports. All
available data were reported.
RESULTS OF FUNDOPLICATION
Operative complications
The most serious operative complication is that ofesophageal or gastric perforation.
This has been reported to occur in 13 of 1451 reported cases (0.9 percent). The incidence
after the open procedure is reported as one to two percent [6, 26]. Ifa perforation is iden-
tified at the time ofsurgery, and appropriately treated, this does not lead to any significant
problems. A missed perforation results in leakage and peritonitis followed by severe com-
plications and carries a 20 to 50 percent mortality [26]. Bleeding that requires transfusion
has been reported in nine of 1451 cases (0.6 percent). Pleural damage and pneumothorax
occurred in eight of 1451 cases (0.6 percent). This is usually of no consequence and can
be treated by simply reinflating the lungs at the end ofthe procedure without the need for
the placement of a chest tube. The rate ofsplenectomy is extremely low, with no splenec-
tomies reported in the 1992 cases reviewed in the literature over the last four years. This
is a definite improvement on the two to five percent splenectomy rate for the open proce-
dure [6, 26-28]. The long-term benefits ofthis are self-evident.
The need for conversion to the open procedure has occurred in 4.8 percent (96/1992)
of cases. This has been reported as being due to difficulty with exposure, bowel perfora-
tion, bleeding, CO2 retention and pneumothorax. This was necessary in five ofourfirst 32
cases, but in our last 300 consecutive cases we have not found the need to convert any of
our cases to the open procedure. There is a definite "learning curve" indicating the need
for proctoring in at least the first 10 cases of a surgeon's experience.
The mortality for the procedure is somewhat less than for the open procedure with
only two of 1992 cases (0.1 percent) resulting in mortality. This compares favorably with
a mortality rate that is closer to one percent after the open procedure [6, 26-28].
Postoperative course
In our recent experience, we have found no need for nasogastric intubation after
surgery and have allowed ourpatients to drink on the evening ofsurgery. They are encour-
aged to eat a light breakfast the next morning, and most patients are able to leave the hos-
pital on the first post-operative day. They may return to work within one or two weeks
after the surgery.
Recurrence ofreflux
DeMeester et al. reported a more than 90 percent efficacy in curing patients (n = 100)
of reflux symptoms at 10 years of follow-up with the open Nissen fundoplication. The
reported incidence of recurrent reflux symptoms after the laparoscopic Nissen fundopli-
cation is 3.4 percent, with an incidence of 11 out of 1451 (0.8 percent) of re-operation.
The follow-up, however, remains short, with a mean time ofabout two years (range: 0 to
36 months). Re-operation can been carried out via the laparoscopic route with good
results. Some of these failures may be due to the "short esophagus," and some surgeons
feel that mostpatients with recurrent reflux symptoms should have athoracotomy with the
option of an esophageal lengthening procedure. There are, however, no clear data to sup-
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Dysphagia
The reported incidence of early postoperative dysphagia varies; however, most
patients will usually complain ofsome dysphagia in the first few weeks after surgery. Late
dysphagia, mostly mild and infrequent, is reported in 86 out of 1090 cases (7.9 percent).
This can usually be easily treated with esophageal dilatation and rarely will result in the
need forreoperation. Ofthe 1090 patients available forreview, 3.5 percentrequired dilata-
tion after the laparoscopic Nissen fundoplication.
Other side-effects
In our series, eight percent (16/198) of patients have required esophagogastroduo-
denoscopy. This showed no endoscopic abnormality in 56 percent (9/16) of cases, gastri-
tis in 38 percent (6/16) ofcases, and one patient had a prepyloric gastric ulcer that healed
on medical therapy.
"Gas bloat" syndrome is probably due to the trapping ofgas in the stomach and small
bowel by the competent anti-reflux barrier at the cardioesophageal junction. These
patients may have learned to repeatedly swallow saliva and air before surgery in an
attempt to clear the esophagus of refluxed gastric acid. This habit may persist into the
postoperative period resulting in aerophagia. This syndrome can be difficult to treat and
may be troublesome to some patients. The reported incidence varies between 0 percent
and 24 percent [8-25]. Other symptoms include persistent diarrhea, which may be due to
inadvertent vagotomy or the induction of rapid gastric emptying by the fundoplication,
chest pain, bloating and belching.
HALT OF PROGRESSION OF COMPLICATIONS
Strictures
Fundoplication has been found to be extremely effective in decreasing the need for
further dilatation ofreflux-induced esophageal strictures. On review ofour recent experi-
ence, only 11 percent ofpatients with a documented preoperative stricture have required
further dilatations afterlaparoscopic fundoplication (unpublished data). In other series, 46
percent of patients on H2 blockers and 30 percent of patients on omeprazole during one
year ofcontinuous medical therapy have required further dilatations for esophageal stric-
tures [29].
Barrett's esophagus
It is not clear whether the progression in extent ofBarrett's esophagus or the progress
to malignancy can be decreased or prevented by fundoplication. It is, however, evident
that the disease does not regress. It is still to be established whether progression to malig-
nancy is slowed. There have been isolated reports of progression to carcinoma of the
esophagus afterfundoplication. Long-term epidemiologic studies are required to establish
the efficacy of fundoplication in this regard.
COST
The hospital cost of a laparoscopic Nissen fundoplication has been reported at
between $6000 and $28,000 in different geographic areas [5]. The mean hospital cost
appears to be in the area of$10,000. This equates to five years ofcontinuous medical ther-
apy. It is, therefore, cost-effective to offer surgical therapy to young patients with severe
disease. A further advantage ofthe laparoscopic procedure over long-term medical thera-
py is the early return to normal activity after surgery and the decreased need for frequent
physician visits and time off work. In this age of cost containment and managed care,
these considerations in the management of the disease may become increasingly impor-
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CONCLUSION
Laparoscopic antireflux surgery has excited the interest not only of surgeons but also
that of gastroenterologists and patients suffering from chronic reflux disease. The early
results after five years ofexperience with the laparoscopic Nissen fundoplication indicates
that this procedure is an attractive alternative to long-term medical therapy with the ben-
efit ofconvenience, safety, minimal complications and low cost. The excellent short-term
results suggest that the long-term results will be at least as good as for the open procedure.
Results from long-term analysis oflarge numbers ofpatients afterlaparoscopic anti-reflux
surgery will soon be available to support this statement.
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